{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-25-029721","form_type":"8-K","ticker":"AYTU","cik":"0001385818","company_name":"AYTU BIOPHARMA, INC","filed_at":"2025-09-23T23:59:59+00:00","discovered_at":"2026-05-14T18:02:43.862630+00:00","generated_at":"2026-05-17T05:52:09.633363+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Aytu BioPharma reports FY2025 net revenue $66.4M, net loss $13.6M; plans EXXUA launch in Q4 2025","bullets":["Full year net revenue $66.4M (+2% YoY); net loss $13.6M vs $15.8M prior year; adjusted EBITDA $9.2M.","Q4 net revenue $15.1M (+4% YoY); net loss $19.8M vs $4.6M prior year (incl. $18.1M impairment and derivative losses).","ADHD Portfolio net revenue $57.6M (flat YoY); Pediatric Portfolio $8.8M (+20% YoY).","Cash $31.0M at June 30, 2025; 9th consecutive quarter of positive adjusted EBITDA.","EXXUA (gepirone) for MDD launch on track for Q4 2025; entering >$22B US MDD market with novel first-in-class agent."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-25-029721","json":"https://secwatch.observer/filing/0001437749-25-029721.json","markdown":"https://secwatch.observer/filing/0001437749-25-029721.md","text":"https://secwatch.observer/filing/0001437749-25-029721.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1385818/000143774925029721/0001437749-25-029721-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1385818/000143774925029721/aytu20250514_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T05:52:09.633363+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}